Global Alpha-1 Antitrypsin Drugs market size is predicted to grow from US$ 1509 million in 2025 to US$ 2491 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031. Get Access Now!

Global Alpha-1 Antitrypsin Drugs Market Size and Outlook 2025-31

The global Alpha-1 Antitrypsin Drugs market size is predicted to grow from US$ 1509 million in 2025 to US$ 2491 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Alpha-1 Antitrypsin Drugs Industry Forecast looks at past sales and reviews total world Alpha-1 Antitrypsin Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Alpha-1 Antitrypsin Drugs sales for 2025 through 2031. With Alpha-1 Antitrypsin Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alpha-1 Antitrypsin Drugs industry. This Insight Report provides a comprehensive analysis of the global Alpha-1 Antitrypsin Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alpha-1 Antitrypsin Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Alpha-1 Antitrypsin Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alpha-1 Antitrypsin Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alpha-1 Antitrypsin Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Alpha-1 Antitrypsin Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Parenteral &nbsp;&nbsp;&nbsp; Inhalation Segmentation by Application: &nbsp;&nbsp;&nbsp; Drugstore &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Baxter &nbsp;&nbsp;&nbsp; CSL Behring &nbsp;&nbsp;&nbsp; Grifols &nbsp;&nbsp;&nbsp; Kamada &nbsp;&nbsp;&nbsp; Abeona Therapeutics &nbsp;&nbsp;&nbsp; Alnylam Pharmaceuticals &nbsp;&nbsp;&nbsp; Applied Genetic Technologies Corp &nbsp;&nbsp;&nbsp; Arrowhead Research Corporation &nbsp;&nbsp;&nbsp; Baxalta Key Questions Addressed in this Report What is the 10-year outlook for the global Alpha-1 Antitrypsin Drugs market? What factors are driving Alpha-1 Antitrypsin Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Alpha-1 Antitrypsin Drugs market opportunities vary by end market size? How does Alpha-1 Antitrypsin Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Alpha-1 Antitrypsin Drugs Segment by Type &nbsp;2.2.1 Parenteral &nbsp;2.2.2 Inhalation &nbsp;2.3 Alpha-1 Antitrypsin Drugs Sales by Type &nbsp;2.3.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Alpha-1 Antitrypsin Drugs Segment by Application &nbsp;2.4.1 Drugstore &nbsp;2.4.2 Hospital &nbsp;2.4.3 Others &nbsp;2.5 Alpha-1 Antitrypsin Drugs Sales by Application &nbsp;2.5.1 Global Alpha-1 Antitrypsin Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Alpha-1 Antitrypsin Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Alpha-1 Antitrypsin Drugs Breakdown Data by Company &nbsp;3.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Alpha-1 Antitrypsin Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Alpha-1 Antitrypsin Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Alpha-1 Antitrypsin Drugs Product Location Distribution &nbsp;3.4.2 Players Alpha-1 Antitrypsin Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Alpha-1 Antitrypsin Drugs by Geographic Region &nbsp;4.1 World Historic Alpha-1 Antitrypsin Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Alpha-1 Antitrypsin Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Alpha-1 Antitrypsin Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Alpha-1 Antitrypsin Drugs Sales Growth &nbsp;4.4 APAC Alpha-1 Antitrypsin Drugs Sales Growth &nbsp;4.5 Europe Alpha-1 Antitrypsin Drugs Sales Growth &nbsp;4.6 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country &nbsp;5.1.1 Americas Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Alpha-1 Antitrypsin Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Alpha-1 Antitrypsin Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region &nbsp;6.1.1 APAC Alpha-1 Antitrypsin Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Alpha-1 Antitrypsin Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Alpha-1 Antitrypsin Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Alpha-1 Antitrypsin Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Alpha-1 Antitrypsin Drugs by Country &nbsp;7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Alpha-1 Antitrypsin Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Alpha-1 Antitrypsin Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Alpha-1 Antitrypsin Drugs by Country &nbsp;8.1.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Alpha-1 Antitrypsin Drugs &nbsp;10.3 Manufacturing Process Analysis of Alpha-1 Antitrypsin Drugs &nbsp;10.4 Industry Chain Structure of Alpha-1 Antitrypsin Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Alpha-1 Antitrypsin Drugs Distributors &nbsp;11.3 Alpha-1 Antitrypsin Drugs Customer 12 World Forecast Review for Alpha-1 Antitrypsin Drugs by Geographic Region &nbsp;12.1 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Alpha-1 Antitrypsin Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Alpha-1 Antitrypsin Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Alpha-1 Antitrypsin Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Alpha-1 Antitrypsin Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Baxter &nbsp;13.1.1 Baxter Company Information &nbsp;13.1.2 Baxter Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Baxter Main Business Overview &nbsp;13.1.5 Baxter Latest Developments &nbsp;13.2 CSL Behring &nbsp;13.2.1 CSL Behring Company Information &nbsp;13.2.2 CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 CSL Behring Main Business Overview &nbsp;13.2.5 CSL Behring Latest Developments &nbsp;13.3 Grifols &nbsp;13.3.1 Grifols Company Information &nbsp;13.3.2 Grifols Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Grifols Main Business Overview &nbsp;13.3.5 Grifols Latest Developments &nbsp;13.4 Kamada &nbsp;13.4.1 Kamada Company Information &nbsp;13.4.2 Kamada Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Kamada Main Business Overview &nbsp;13.4.5 Kamada Latest Developments &nbsp;13.5 Abeona Therapeutics &nbsp;13.5.1 Abeona Therapeutics Company Information &nbsp;13.5.2 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Abeona Therapeutics Main Business Overview &nbsp;13.5.5 Abeona Therapeutics Latest Developments &nbsp;13.6 Alnylam Pharmaceuticals &nbsp;13.6.1 Alnylam Pharmaceuticals Company Information &nbsp;13.6.2 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Alnylam Pharmaceuticals Main Business Overview &nbsp;13.6.5 Alnylam Pharmaceuticals Latest Developments &nbsp;13.7 Applied Genetic Technologies Corp &nbsp;13.7.1 Applied Genetic Technologies Corp Company Information &nbsp;13.7.2 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Applied Genetic Technologies Corp Main Business Overview &nbsp;13.7.5 Applied Genetic Technologies Corp Latest Developments &nbsp;13.8 Arrowhead Research Corporation &nbsp;13.8.1 Arrowhead Research Corporation Company Information &nbsp;13.8.2 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Arrowhead Research Corporation Main Business Overview &nbsp;13.8.5 Arrowhead Research Corporation Latest Developments &nbsp;13.9 Baxalta &nbsp;13.9.1 Baxalta Company Information &nbsp;13.9.2 Baxalta Alpha-1 Antitrypsin Drugs Product Portfolios and Specifications &nbsp;13.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Baxalta Main Business Overview &nbsp;13.9.5 Baxalta Latest Developments 14 Research Findings and Conclusion

Report	Global Alpha-1 Antitrypsin Drugs Market Growth 2025-2031
Selected License	Single ID:LPI23012

Buyer Information

Order Summary